Legacy Trust Amgen Inc Transaction History

Legacy Trust

$402 Billion
Q2 2024

A detailed history of Legacy Trust transactions in Amgen Inc stock. As of the latest transaction made, Legacy Trust holds 2,814 shares of AMGN stock, worth $935,514. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,814

Previous 2,844 1.05%

Holding current value

$935,514

Previous $809 Million 8.73%

% of portfolio

0.22%

Previous 0.2%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $7,882 - $9,579	-30 Reduced 1.05%	2,814 $879 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $8,438 - $9,519	-33 Reduced 1.15%	2,844 $819 Million
Q3 2023 Oct 16, 2023	SELL	$218.65 - $271.46 $393,570 - $488,627	-1,800 Reduced 38.49%	2,877 $773 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $52,067 - $61,568	243 Added 5.48%	4,677 $1.04 Billion
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $11,515 - $14,035	-51 Reduced 1.14%	4,434 $1.07 Billion
Q4 2022 Apr 03, 2023	BUY	$229.03 - $291.01 $1.03 Million - $1.31 Million	4,485 New	4,485 $1.18 Billion

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Trust, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Trust with notifications on news.

Account